HK1222794A1 - 預防或治療左心室重塑的方法 - Google Patents
預防或治療左心室重塑的方法Info
- Publication number
- HK1222794A1 HK1222794A1 HK16110985.8A HK16110985A HK1222794A1 HK 1222794 A1 HK1222794 A1 HK 1222794A1 HK 16110985 A HK16110985 A HK 16110985A HK 1222794 A1 HK1222794 A1 HK 1222794A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- prevention
- treatment
- methods
- left ventricle
- ventricle remodeling
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361823305P | 2013-05-14 | 2013-05-14 | |
PCT/US2013/066212 WO2014185952A1 (en) | 2013-05-14 | 2013-10-22 | Methods for the prevention or treatment of left ventricle remodeling |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1222794A1 true HK1222794A1 (zh) | 2017-07-14 |
Family
ID=51898747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16110985.8A HK1222794A1 (zh) | 2013-05-14 | 2016-09-19 | 預防或治療左心室重塑的方法 |
Country Status (7)
Country | Link |
---|---|
US (3) | US20160256514A1 (zh) |
EP (2) | EP2996707B1 (zh) |
JP (2) | JP2016522196A (zh) |
CN (2) | CN105579054A (zh) |
CA (1) | CA2912386A1 (zh) |
HK (1) | HK1222794A1 (zh) |
WO (1) | WO2014185952A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20180318381A1 (en) * | 2015-10-23 | 2018-11-08 | University Of Pittsburgh- Of The Commonwealth System Of Higher Education | Methods of Treatment of Rhabdomyolysis |
US11034724B2 (en) | 2017-04-05 | 2021-06-15 | Stealth Biotherapeutics Corp. | Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2 |
CN108042525B (zh) * | 2017-12-20 | 2020-09-01 | 岳红 | 一种治疗心肌梗死后心室重塑的药物组合物 |
US10676506B2 (en) | 2018-01-26 | 2020-06-09 | Stealth Biotherapeutics Corp. | Crystalline bis- and tris-hydrochloride salt of elamipretide |
GB202000945D0 (en) * | 2020-01-22 | 2020-03-04 | Univ Oslo | Treatment of cardiac remodelling |
US20230256047A1 (en) * | 2020-06-17 | 2023-08-17 | Stealth Biotherapeutics Inc. | Methods and compositions for the treatment of muscular dystrophy |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
US5716644A (en) | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
US5674534A (en) | 1992-06-11 | 1997-10-07 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
CA2622911C (en) * | 2005-09-16 | 2016-12-06 | Cornell Research Foundation, Inc. | Methods for reducing cd36 expression |
EP2944317A1 (en) * | 2009-10-05 | 2015-11-18 | Cornell University | Methods for the prevention or treatment of heart failure |
WO2011082328A1 (en) * | 2009-12-31 | 2011-07-07 | Stealth Peptides International, Inc. | Methods for performing a coronary artery bypass graft procedure |
CA2786280A1 (en) * | 2009-12-31 | 2011-07-07 | Stealth Peptides International, Inc. | Methods for the prevention or treatment of vessel occlusion injury |
EP2808029A3 (en) * | 2010-03-15 | 2015-04-01 | Stealth Peptides International, Inc. | Combination therapies using cyclosporine and aromatic cationic peptides |
CN106620645A (zh) * | 2010-07-09 | 2017-05-10 | 康德生物医疗技术公司 | 预防或治疗缺血/再灌注损伤之后无复流的方法 |
US20140045758A1 (en) * | 2011-02-21 | 2014-02-13 | The Trustees Of Columbia University In The City Of New York | Methods for Treating and Preventing Cardiac Dysfunction in Septic Shock |
CA3123992C (en) * | 2011-09-29 | 2024-06-04 | Mayo Foundation For Medical Education And Research | Aromatic-cationic peptides and methods for using same |
-
2013
- 2013-10-22 JP JP2016513938A patent/JP2016522196A/ja active Pending
- 2013-10-22 EP EP13884895.7A patent/EP2996707B1/en active Active
- 2013-10-22 US US14/891,205 patent/US20160256514A1/en not_active Abandoned
- 2013-10-22 CN CN201380078124.5A patent/CN105579054A/zh active Pending
- 2013-10-22 EP EP19172063.0A patent/EP3586864A1/en active Pending
- 2013-10-22 WO PCT/US2013/066212 patent/WO2014185952A1/en active Application Filing
- 2013-10-22 CA CA2912386A patent/CA2912386A1/en active Pending
- 2013-10-22 CN CN201811549998.5A patent/CN110051843A/zh active Pending
-
2016
- 2016-09-19 HK HK16110985.8A patent/HK1222794A1/zh unknown
-
2018
- 2018-11-08 JP JP2018210291A patent/JP2019052157A/ja active Pending
- 2018-11-15 US US16/192,728 patent/US20190358286A1/en not_active Abandoned
-
2022
- 2022-02-25 US US17/680,842 patent/US20220296671A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2996707B1 (en) | 2019-09-11 |
EP3586864A1 (en) | 2020-01-01 |
CN110051843A (zh) | 2019-07-26 |
CN105579054A (zh) | 2016-05-11 |
CA2912386A1 (en) | 2014-11-20 |
EP2996707A4 (en) | 2016-12-07 |
US20160256514A1 (en) | 2016-09-08 |
US20220296671A1 (en) | 2022-09-22 |
US20190358286A1 (en) | 2019-11-28 |
JP2016522196A (ja) | 2016-07-28 |
JP2019052157A (ja) | 2019-04-04 |
WO2014185952A1 (en) | 2014-11-20 |
EP2996707A1 (en) | 2016-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL278018A (en) | Methods for the treatment or prevention of ophthalmological conditions | |
IL243976A0 (en) | kdm1a inhibitors for disease treatment | |
HK1246776A1 (zh) | 用於hiv治療的異喹啉化合物 | |
EP2945639A4 (en) | METHOD FOR THE TREATMENT OF HEART DISEASES | |
IL248767B (en) | Trimethoxyphenyl-benzaimidazole compounds for cancer treatment | |
PL3524255T3 (pl) | Kompozycja do leczenia trądziku | |
HK1222794A1 (zh) | 預防或治療左心室重塑的方法 | |
HK1219653A1 (zh) | 治療線粒體疾病的方法 | |
HK1215164A1 (zh) | 處理方法 | |
HK1220374A1 (zh) | 用於治療碳氧血紅蛋白血症的組合物和方法 | |
SG11201702700UA (en) | Methods for the treatment of peri-implantitis | |
HK1223547A1 (zh) | 癌症治療方法 | |
HK1216391A1 (zh) | 組合治療 | |
PL3087035T3 (pl) | Sposób biocydowego przetwarzania przemysłowych obiegów wodnych | |
EP2953631A4 (en) | Methods of treating heart failure | |
HK1221681A1 (zh) | 用於治療神經退化的方法 | |
EP3145525A4 (en) | Use of microperoxidases for the treatment of carboxyhemoglobinemia | |
PT3049085T (pt) | Inibidores de sgk1 no tratamento da síndrome do qt longo | |
PL3016948T3 (pl) | 2-acyloaminotiazole do leczenia nowotworów | |
GB201316043D0 (en) | Cardiac arrest treatment | |
PT3524255T (pt) | Composição para o tratamento do acne | |
GB201412293D0 (en) | Therapeutic treatments | |
GB201412285D0 (en) | Therapeutic treatments | |
AU2013903592A0 (en) | Vaccines for the treatment or prevention of cancer |